Alpinia oxyphylla Miq. extract prevents diabetes in mice by modulating gut microbiota

Journal of Diabetes Research

Volumn 2018, Issue , 2018, Pages

  Xie, Yiqiang ^a   Xiao, Man ^a   Ni, ^a   Jiang, Shangfei ^a   Feng, Guizhu ^a   Sang, Shenggang ^a   Du, Guankui ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPINIA OXYPHYLLA EXTRACT; ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; PLANT EXTRACT; RNA 16S; UNCLASSIFIED DRUG; FRUIT EXTRACT, ALPINIA OXYPHYLLA;

AKKERMANSIA; ALPINIA; ALPINIA OXYPHYLLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BACTEROIDES; BACTEROIDETES; BLAUTIA; CONTROLLED STUDY; CYANOBACTERIUM; DB/DB MOUSE; DRUG DOSE COMPARISON; FECES MICROFLORA; FIRMICUTES; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HELICOBACTER; INTESTINE FLORA; KIDNEY TISSUE; LACHNOSPIRACEAE; LACTOBACILLACEAE; MALE; MEDICINAL PLANT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PORPHYROMONADACEAE; URINARY EXCRETION; VERRUCOMICROBIA; ANIMAL; BLOOD; DRUG EFFECT; FECES; GASTROINTESTINAL TRACT; GLUCOSE TOLERANCE TEST; METABOLISM; MICROBIOLOGY;

ALPINIA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GLUCOSE TOLERANCE TEST; MALE; MICE; PLANT EXTRACTS;

EID: 85055646080     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2018/4230590     Document Type: Article

References (49)

1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, "Global estimates of the prevalence of diabetes for 2010 and 2030, " Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4-14, 2010.
2. D. LeRoith, "Hyperglycemia, hypertension, and dyslipidemia in type 2 diabetes mellitus: goals for diabetes management, " Clinical Cornerstone, vol. 9, pp. S8-S16, 2008.
3. M. Guo, S. D. Ricardo, J. A. Deane, M. Shi, L. Cullen-McEwen, and J. F. Bertram, "A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy, " Journal of Anatomy, vol. 207, no. 6, pp. 813-821, 2005.
4. S. Ussar, S. Fujisaka, and C. R. Kahn, "Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome, " Molecular Metabolism, vol. 5, no. 9, pp. 795-803, 2016.
5. G. M. Barlow, A. Yu, and R. Mathur, "Role of the gut microbiome in obesity and diabetes mellitus, " Nutrition in Clinical Practice, vol. 30, no. 6, pp. 787-797, 2015.
6. M. Sasaki, N. Ogasawara, Y. Funaki et al., "Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: A randomized double-blind, placebo-controlled study, " BMC Gastroenterology, vol. 13, no. 1, p. 81, 2013.
7. J. Graessler, Y. Qin, H. Zhong et al., "Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters, " The Pharmacogenomics Journal, vol. 13, no. 6, pp. 514-522, 2013.
8. L. Wang, C. T. Christophersen, M. J. Sorich, J. P. Gerber, M. T. Angley, and M. A. Conlon, "Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism, " Applied and Environmental Microbiology, vol. 77, no. 18, pp. 6718-6721, 2011.
9. M. Derrien, C. Belzer, and W. M. de Vos, "Akkermansia muciniphila and its role in regulating host functions, " Microbial Pathogenesis, vol. 106, pp. 171-181, 2017.
10. X. Li, J. Guo, K. Ji, and P. Zhang, "Bamboo shoot fiber prevents obesity in mice by modulating the gut microbiota, " Scientific Reports, vol. 6, no. 1, p. 32953, 2016.
11. C. Kang, Y. Zhang, X. Zhu et al., "Healthy subjects differentially respond to dietary capsaicin correlating with specific gut enterotypes, " The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 12, pp. 4681-4689, 2016.
12. F. F. Anhê, D. Roy, G. Pilon et al., "A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice, " Gut, vol. 64, no. 6, pp. 872-883, 2015.
13. D. E. Roopchand, R. N. Carmody, P. Kuhn et al., "Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome, " Diabetes, vol. 64, no. 8, pp. 2847-2858, 2015.
14. F. F. Anhe, G. Pilon, D. Roy, Y. Desjardins, E. Levy, and A. Marette, "Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome?, " Gut Microbes, vol. 7, no. 2, pp. 146-153, 2016.
15. N. R. Shin, J. C. Lee, H. Y. Lee et al., "An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice, " Gut, vol. 63, no. 5, pp. 727-735, 2014.
16. S.-H. Shi, X. Zhao, B. Liu et al., "The effects of sesquiterpenesrich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 451802, 11 pages, 2014.
17. S. Wang, Y. Zhao, J. Zhang et al., "Antidiarrheal effect of Alpinia oxyphylla Miq.(Zingiberaceae) in experimental mice and its possible mechanism of action, " Journal of Ethnopharmacology, vol. 168, pp. 182-190, 2015.
18. Q. Zhang, C. Cui, C.-Q. Chen et al., "Anti-proliferative and pro-Apoptotic activities of Alpinia oxyphylla on HepG2 cells through ROS-mediated signaling pathway, " Journal of Ethnopharmacology, vol. 169, pp. 99-108, 2015.
19. L. J. An, S. Guan, G. F. Shi, Y. M. Bao, Y. L. Duan, and B. Jiang, "Protocatechuic acid from Alpinia oxyphylla against MPP+ -induced neurotoxicity in PC12 cells, " Food and Chemical Toxicology, vol. 44, no. 3, pp. 436-443, 2006.
20. G.-F. Shi, L.-J. An, B. Jiang, S. Guan, and Y.-M. Bao, "Alpinia protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo, " Neuroscience Letters, vol. 403, no. 3, pp. 206-210, 2006.
21. H. Wang, T.-Q. Liu, S. Guan, Y.-X. Zhu, and Z.-F. Cui, "Protocatechuic acid from Alpinia oxyphylla promotes migration of human adipose tissue-derived stromal cells in vitro, " European Journal of Pharmacology, vol. 599, no. 1-3, pp. 24-31, 2008.
22. H. Wang, T.-Q. Liu, Y.-X. Zhu, S. Guan, X.-H. Ma, and Z.-F. Cui, "Effect of protocatechuic acid from Alpinia oxyphylla on proliferation of human adipose tissue-derived stromal cells in vitro, " Molecular and Cellular Biochemistry, vol. 330, no. 1-2, pp. 47-53, 2009.
23. Y. Xie, M. Xiao, D. Li et al., "Anti-diabetic effect of Alpinia oxyphylla extract on 57BL/KsJ db-/db-mice, " Experimental and Therapeutic Medicine, vol. 13, no. 4, pp. 1321-1328, 2017.
24. G. Du, M. Xiao, X. Zhang et al., "Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db-mouse kidney, " Biological Research, vol. 50, no. 1, p. 9, 2017.
25. W. Nicklas, P. Baneux, R. Boot et al., "Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units, " Laboratory Animals, vol. 36, no. 1, pp. 20-42, 2002.
26. J. A. Lott and K. Turner, "Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine, " Clinical Chemistry, vol. 21, no. 12, pp. 1754-1760, 1975.
27. R. Katafuchi, Y. Kiyoshi, Y. Oh et al., "Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation, " Clinical Nephrology, vol. 49, no. 1, pp. 1-8, 1998.
28. T. Magoc and S. L. Salzberg, "FLASH: fast length adjustment of short reads to improve genome assemblies, " Bioinformatics, vol. 27, no. 21, pp. 2957-2963, 2011.
29. T. Z. DeSantis, P. Hugenholtz, N. Larsen et al., "Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB, " Applied and Environmental Microbiology, vol. 72, no. 7, pp. 5069-5072, 2006.
30. R. C. Edgar, "UPARSE: highly accurate OTU sequences from microbial amplicon reads, " Nature Methods, vol. 10, no. 10, pp. 996-998, 2013.
31. T. Braak, J. F. Cajo, and P. Smilauer, "CANOCO reference manual and CanoDraw for Windows user's guide: software for canonical community ordination (version 4.5), " 2002, http://www.canoco.com.
32. A. P. Rolo and C. M. Palmeira, "Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, " Toxicology and Applied Pharmacology, vol. 212, no. 2, pp. 167-178, 2006.
33. Y. Ihara, S. Toyokuni, K. Uchida et al., "Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes, " Diabetes, vol. 48, no. 4, pp. 927-932, 1999.
34. N. Larsen, F. K. Vogensen, F. W. J. van den Berg et al., "Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults, " PLoS One, vol. 5, no. 2, article e9085, 2010.
35. M. Murri, I. Leiva, J. M. Gomez-Zumaquero et al., "Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study, " BMC Medicine, vol. 11, no. 1, p. 46, 2013.
36. L. Geurts, V. Lazarevic, M. Derrien et al., "Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue, " Frontiers in Microbiology, vol. 2, p. 149, 2011.
37. L. Krych, D. S. Nielsen, A. K. Hansen, and C. H. Hansen, "Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice, " Gut Microbes, vol. 6, no. 2, pp. 101-109, 2015.
38. K. J. Wolf, J. G. Daft, S. M. Tanner, R. Hartmann, E. Khafipour, and R. G. Lorenz, "Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice, " Journal of Histochemistry and Cytochemistry, vol. 62, no. 4, pp. 237-250, 2014.
39. M. Balfegò, S. Canivell, F. A. Hanzu et al., "Effects of sardineenriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: A pilot randomized trial, " Lipids in Health and Disease, vol. 15, no. 1, p. 78, 2016.
40. S. Zhao, W. Liu, J. Wang et al., "Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice, " Journal of Molecular Endocrinology, vol. 58, no. 1, pp. 1-14, 2017.
41. J. Li, S. Lin, P. M. Vanhoutte, C. W. Woo, and A. Xu, "Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe- mice, " Circulation, vol. 133, no. 24, pp. 2434-2446, 2016.
42. R. L. Greer, X. Dong, A. C. F. Moraes et al., "Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism, " Nature Communications, vol. 7, p. 13329, 2016.
43. M. C. Dao, A. Everard, J. Aron-Wisnewsky et al., "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, " Gut, vol. 65, no. 3, pp. 426-436, 2016.
44. M. Schneeberger, A. Everard, A. G. Gomez-Valades et al., "Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice, " Scientific Reports, vol. 5, no. 1, p. 16643, 2015.
45. M. Yan, M. M. Song, R. X. Bai, S. Cheng, and W. M. Yan, "Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila, " World Journal of Gastrointestinal Surgery, vol. 8, no. 4, pp. 301-307, 2016.
46. L. R. Malamug, R. Karnchanasorn, R. Samoa, and K. C. Chiu, "The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance, " Scientifica, vol. 2014, Article ID 870165, 7 pages, 2014.
47. T. Kozyrieva, E. Kolesnikova, and I. Shut, "Correlation of Helicobacter pylori infection with development of cardiovascular risk in patients with coronary heart disease in association with type 2 diabetes mellitus, " Georgian Medical News, vol. 256-257, pp. 24-29, 2016.
48. K. Tsang and S. Lam, "Extragastroduodenal conditions associated with Helicobacter pylori infection, " Hong Kong Medical Journal, vol. 5, no. 2, pp. 169-174, 1999.
49. W. A. Nasif, M. H. Mukhtar, M. M. Nour Eldein, and S. S. Ashgar, "Oxidative DNA damage and oxidized low density lipoprotein in type II diabetes mellitus among patients with Helicobacter pylori infection, " Diabetology & Metabolic Syndrome, vol. 8, no. 1, p. 34, 2016.